Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

23. October 2018

Epigenomics AG successfully completes capital increase; gross proceeds of EUR 22.3 million

Read more

16. October 2018

Epigenomics AG sets subscription price at EUR 1.86 per new share

Read more

03. October 2018

Epigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase

Read more

Press releases

07. November 2018

Epigenomics AG Announces 2018 Third Quarter and Nine Months Financial Results

Read more

31. October 2018

Epigenomics AG Announces Veterans Administration’s Adherence Study using Epi proColon® Colorectal Cancer Screening Blood Test

Read more

29. October 2018

Epigenomics AG obtains CE Mark for Liquid Biopsy Test for Liver Cancer Detection

Read more